SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Biomedica, (OXB).

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oily1 who started this subject8/18/2004 2:53:12 AM
From: Oily1   of 111
 
Appointment of Broker

RNS Number:0669C
Oxford Biomedica PLC
18 August 2004

FOR IMMEDIATE RELEASE 18 August 2004

OXFORD BIOMEDICA PLC

Appointment of Broker

Oxford, UK: 18 August 2004 - Oxford BioMedica (LSE:OXB.L), the leading gene
therapy company, is pleased to announce the appointment of Panmure Gordon, a
division of Lazard & Co., Limited, as its broker with immediate effect.

-Ends-
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext